Concepedia

Stéphanie Herveau

SH

6

Publications

240

Citations

6

H-Index

2009

Active since

Affiliations

Inserm(Current)

Centre de Recherche en Cancérologie de Lyon

Université Claude Bernard Lyon 1

Hospices Civils de Lyon

Stéphanie Herveau is an author at Inserm specializing in medicine, cell biology, and cell signaling.

Top concepts

Publications per year

2009–2013

6

Publications

6

Preclinical Studies on the Mechanism of Action and the Anti-Lymphoma Activity of the Novel Anti-CD20 Antibody GA101

Stéphane Dalle, Lina Reslan, Timothee Besseyre de Horts et al. · Molecular Cancer Therapeutics · 2011 · 127 citations · Full text

Transfection of cells in suspension by ultrasound cavitation

Lina Reslan, Jean‐Louis Mestas, Stéphanie Herveau et al. · Journal of Controlled Release · 2009 · 45 citations

, , +8

Tubulin binding cofactor C (TBCC) suppresses tumor growth and enhances chemosensitivity in human breast cancer cells

Rouba Hage‐Sleiman, Stéphanie Herveau, Eva‐Laure Matera et al. · BMC Cancer · 2010 · 28 citations · Full text

Therapeutic Enhancement of ER Stress by Insulin-Like Growth Factor I Sensitizes Myeloma Cells to Proteasomal Inhibitors

Inès Tagoug, Lars Petter Jordheim, Stéphanie Herveau et al. · Clinical Cancer Research · 2013 · 16 citations · Full text

Silencing of <i>Tubulin Binding Cofactor C</i> Modifies Microtubule Dynamics and Cell Cycle Distribution and Enhances Sensitivity to Gemcitabine in Breast Cancer Cells

Rouba Hage‐Sleiman, Stéphanie Herveau, Eva‐Laure Matera et al. · Molecular Cancer Therapeutics · 2011 · 13 citations

Rows per page

1–5 of 6